Anthera Pharmaceuticals Raises $19M
San Mateo-based Anthera Pharmaceuticals announced Wednesday that the firm has raised $19M in an equity financing for the firm's anti-inflammatory drugs. The funding came from Caxton Advantage Life Sciences Fund and HBM BioCapital, which led the round. Existing investors VantagePoint Venture Partners, Sofinnova Ventures, Pappas Ventures and Mitsubishi International Corporation also participated. Anthera said that Rachel Leheny, Ph.D. of Caxton will join the firm's board as part of the funding.
posted on Wednesday, August 13, 2008 (Link to more information)
Related companies:
Anthera Pharmaceuticals
Related stories:
> Anthera Pharmaceuticals Raises $36M
> Bridge Pharmaceuticals Raises $35M
> MicuRx Raises $10M
> Third Rock Ventures Raises $426M Fund, Sets Up Shop In San Francisco
> MAP Pharmaceuticals Raises $50M
silicontap.com Home